Nitrolingual (Glyceryl Trinitrate)

Glyceryl trinitrate, the active ingredient in Nitrolingual, is a nitrate vasodilator presented as a 0.4 mg per spray oro‑mucosal spray for oromucosal use. It rapidly relieves acute angina pectoris and is employed for prophylaxis of angina attacks in adult patients by donating nitric oxide to dilate coronary vessels.

GNH USA supplies Nitrolingual as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, providing regulatory‑approved batches for global distribution. The company adheres to EU GMP standards and offers reliable logistics for timely delivery.

Nitrolingual (glyceryl trinitrate) is a nitrate vasodilator used in the management of coronary artery disease.

Acute angina pectoris: provides rapid relief of chest pain caused by myocardial ischemia. Prophylaxis of angina attacks: reduces the frequency of angina episodes when used before exertion. Variant (Prinzmetal) angina: prevents coronary artery spasm that leads to transient chest discomfort.

Nitrolingual may cause a range of adverse reactions. Patients should be aware of both frequent and less common events.

Common Side Effects: - Headache - Flushing - Dizziness - Hypotension

Serious or Rare Side Effects: - Severe hypotension - Syncope (fainting) - Methemoglobinemia - Allergic reaction, including rash or anaphylaxis

Before prescribing Nitrolingual, clinicians should consider several safety measures.

Assess cardiovascular status: check blood pressure and heart rate prior to use. Avoid concurrent use with phosphodiesterase‑5 inhibitors: risk of profound hypotension. Use with caution in patients with anemia: may worsen symptoms. Limit use in recent myocardial infarction: monitor closely for hemodynamic changes. Store at room temperature: keep in the original container, protect from moisture and light.

Nitrolingual can interact with several drug classes, requiring careful management.

Major Interactions (Avoid): - Sildenafil and other PDE‑5 inhibitors: may cause severe hypotension. - Other nitrates (e.g., isosorbide dinitrate): additive vasodilatory effect. - Alcohol: can amplify blood‑pressure‑lowering actions.

Moderate Interactions (Monitor Closely): - Antihypertensives (ACE inhibitors, beta‑blockers): may enhance blood‑pressure reduction. - Diuretics: risk of volume depletion and hypotension. - Tobacco smoking: may increase tolerance to nitrates, reducing efficacy.